Nintedanib ameliorates imiquimod-induced psoriasis in mice by inhibiting NF-κB and VEGFR2 signaling
Xiaohe Li, Buri Xi, Yang Miao, Xiaoyang Ma, Jianwei Zhang, Jingjing Gao, Wenguo Wei, Honggang Zhou, Cheng Yang
Topics & Concepts
PsoriasisNintedanibHaCaTAngiogenesisKeratinocyteImiquimodCancer researchPharmacologyProinflammatory cytokineIn vivoMedicineInflammationChemistryImmunologyBiologyIn vitroInternal medicineIdiopathic pulmonary fibrosisBiochemistryBiotechnologyLungPsoriasis: Treatment and PathogenesisCytokine Signaling Pathways and InteractionsNF-κB Signaling Pathways